[Experimental ureteral obstruction and knockout animals]

Area of Science:

• Pediatric Nephrology
• Urology
• Developmental Biology

Context:

• Congenital obstructive uropathies are common in newborns and are a primary cause of infant renal disease.
• Surgical correction of urinary tract drainage is standard, but long-term renal health in affected individuals remains a concern.
• Recent animal models demonstrate that temporary ureteral obstruction during development can cause significant renal deterioration later in life.

Purpose:

• To investigate the long-term consequences of neonatal and prenatal ureteral obstruction on renal health.
• To explore the molecular mechanisms underlying tubulointerstitial fibrosis in response to ureteral obstruction.
• To identify potential therapeutic targets for preventing or treating renal fibrosis.

Summary:

• Obstructive uropathies in newborns, often treated surgically, may lead to adult renal disease as shown in animal models where transient ureteral obstruction causes later renal damage.
• Animal models have elucidated the pathways involved in tubulointerstitial fibrosis, a key process in renal deterioration.
• Studies utilizing genetically engineered animals have identified numerous molecules with pro- and anti-fibrotic effects, suggesting novel therapeutic strategies.

Impact:

• Identifies a critical knowledge gap regarding the long-term renal outcomes for infants treated for congenital obstructive uropathies.
• Provides a foundation for developing targeted therapies to prevent or reverse renal fibrosis, a major cause of chronic kidney disease.
• Highlights the potential of novel drug development based on insights from genetically engineered animal models to mitigate progressive renal damage.